Symbols / SY Stock $2.03 +4.10% So-Young International Inc.

Healthcare • Health Information Services • China • NCM
SY (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Health Information Services
CEO Mr. Xing Jin
Exch · Country NCM · China
Market Cap 203.77M
Enterprise Value -145.86M
Income -258.34M
Sales 1.66B
FCF (ttm) —
Book/sh 2.27
Cash/sh 10.33
Employees 2,348
Insider 10d —
IPO May 02, 2019
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -23.85
PEG —
P/S 0.12
P/B 0.90
P/C —
EV/EBITDA 0.66
EV/Sales -0.09
Quick Ratio 1.00
Current Ratio 1.73
Debt/Eq 23.65
LT Debt/Eq —
EPS (ttm) -0.38
EPS next Y -0.09
EPS Growth —
Revenue Growth 45.60%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-21
Earnings (prior) 2026-05-22
ROA -6.61%
ROE -15.04%
ROIC —
Gross Margin 46.03%
Oper. Margin -13.38%
Profit Margin -15.57%
Shs Outstand 84.78M
Shs Float 40.91M
Insider Own 21.69%
Instit Own 21.45%
Short Float 3.53%
Short Ratio 4.77
Short Interest 1.78M
52W High 6.28
vs 52W High -67.68%
52W Low 0.88
vs 52W Low 130.42%
Beta 2.13
Impl. Vol. 12.50%
Rel Volume 1.26
Avg Volume 596.11K
Volume 752.90K
Target (mean) $7.33
Tgt Median $7.33
Tgt Low $4.82
Tgt High $9.84
# Analysts 2
Recom Strong_buy
Prev Close $1.95
Price $2.03
Change 4.10%
About

So-Young International Inc. operates an online platform for consumption healthcare services in the People's Republic of China. The company offers So-Young Mobile App that offers users access to medical aesthetic knowledge, community support and reservation options for treatment with medical professionals, and medical aesthetic institutions; Weixin mini program to explore treatment options, check prices, schedule appointments, participate in online consultations, and track follow-ups; and medical aesthetic community content through its website soyoung.com. Its aesthetic centers offer non-invasive to minimally invasive procedures, including device-based options, such as thread lifts, intense pulsed light, ultrasound facelifts, picosecond lasers, and body contouring treatments, as well as injectable treatments, including skin boosters, hyaluronic acid-based products, botox, and type I and type III collagen. In addition, the company engages in the research and development, production, sale, and distribution of light therapy devices, including excimer laser systems, UV excimer therapy devices, LED and red-light therapy systems, and advanced laser and intense pulsed light technologies; surgical laser devices, including carbon dioxide laser machines, multi-wavelength and semiconductor laser systems for urological treatments, and hydrodynamic-assisted liposuction systems for plastic surgery, as well as pneumatic liquid spray devices skin cleansing. Further, it offers injectable products; sales and technical, maintenance, installation, operational training, error reporting, maintenance, and equipment packaging services; consumption healthcare services, including dermatology, dentistry and orthodontics, physical examinations, gynecology, and postnatal care; reservation services; and content management through beauty diaries, short-form videos, treatment reviews, featured articles, and chat messages. The company was founded in 2013 and is headquartered in Beijing, China.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$7.33
Mean price target
2. Current target
$2.03
Latest analyst target
3. DCF / Fair value
$7.33
Proxy: analyst mean price target (no FCF/EPS data available).
Ratings
Current target
$2.03
Low
$4.82
High
$9.84
Mean
$7.33

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-07-08 up Citigroup Neutral → Buy $6
2024-09-23 down Citigroup Buy → Neutral $1
2023-03-23 main Jefferies — → Buy $3
2023-03-22 up Citigroup Neutral → Buy $3
2021-11-26 main Needham — → Buy $9
2021-03-23 main Canaccord Genuity — → Buy $14
2021-03-23 main Needham — → Buy $14
2020-08-28 main Needham — → Buy $13
2020-05-19 main Canaccord Genuity — → Buy $15
2020-03-24 main Needham — → Buy $15
2019-06-10 init CICC — → Buy $20
2019-05-31 main Canaccord Genuity — → Buy $20
2019-05-28 init Needham — → Buy $17
2019-05-28 init Canaccord Genuity — → Buy $21
News
RSS: Latest SY news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1,523.41
+3.87%
1,466.70
-2.09%
1,498.03
+19.09%
1,257.87
Operating Revenue
1,523.41
+3.87%
1,466.70
-2.09%
1,498.03
+19.09%
1,257.87
Cost Of Revenue
795.72
+40.19%
567.59
+4.27%
544.34
+38.41%
393.29
Reconciled Cost Of Revenue
795.72
+40.19%
567.59
+4.27%
544.34
+38.41%
393.29
Gross Profit
727.69
-19.07%
899.11
-5.72%
953.69
+10.31%
864.58
Operating Expense
994.15
+1.07%
983.60
-3.07%
1,014.74
+4.89%
967.39
Research And Development
137.04
-16.96%
165.03
-18.91%
203.52
-13.43%
235.09
Selling General And Administration
857.11
+4.71%
818.57
+0.91%
811.22
+10.78%
732.30
Selling And Marketing Expense
528.59
+6.90%
494.49
-4.99%
520.45
+10.24%
472.09
General And Administrative Expense
328.52
+1.37%
324.07
+11.46%
290.76
+11.74%
260.21
Other Gand A
328.52
+1.37%
324.07
+11.46%
290.76
+11.74%
260.21
Total Expenses
1,789.88
+15.39%
1,551.18
-0.51%
1,559.08
+14.58%
1,360.68
Operating Income
-266.47
-215.41%
-84.48
-38.39%
-61.05
+40.62%
-102.81
Total Operating Income As Reported
-286.18
+54.17%
-624.49
-922.97%
-61.05
+40.62%
-102.81
EBITDA
-209.25
-442.60%
-38.56
-157.84%
-14.96
+73.16%
-55.72
Normalized EBITDA
-197.23
-139.63%
497.66
+2024.82%
-25.86
+49.84%
-51.55
Reconciled Depreciation
57.21
+24.60%
45.92
-0.37%
46.09
-2.12%
47.09
EBIT
-266.47
-215.41%
-84.48
-38.39%
-61.05
+40.62%
-102.81
Total Unusual Items
-12.02
+97.76%
-536.23
-5020.42%
10.90
+361.16%
-4.17
Total Unusual Items Excluding Goodwill
-12.02
+97.76%
-536.23
-5020.42%
10.90
+361.16%
-4.17
Special Income Charges
-19.71
+96.40%
-547.36
-123179.05%
-0.44
+94.41%
-7.95
Impairment Of Capital Assets
19.71
-96.35%
540.01
0.00
0.00
Write Off
0.00
-100.00%
7.35
+1555.41%
0.44
-94.41%
7.95
Net Income
-242.30
+58.90%
-589.53
-2870.33%
21.28
+132.46%
-65.55
Pretax Income
-246.11
+58.15%
-588.09
-7573.47%
7.87
+109.04%
-87.07
Net Non Operating Interest Income Expense
23.56
-49.35%
46.51
-4.78%
48.84
+69.11%
28.88
Net Interest Income
23.56
-49.35%
46.51
-4.78%
48.84
+69.11%
28.88
Interest Income Non Operating
23.56
-49.35%
46.51
-4.78%
48.84
+69.11%
28.88
Interest Income
23.56
-49.35%
46.51
-4.78%
48.84
+69.11%
28.88
Other Income Expense
-3.20
+99.42%
-550.11
-2840.55%
20.07
+252.65%
-13.15
Other Non Operating Income Expenses
12.90
+1040.76%
1.13
-94.84%
21.90
+165.56%
8.25
Gain On Sale Of Security
7.69
-30.96%
11.13
-1.85%
11.34
+200.69%
3.77
Tax Provision
0.80
+187.96%
-0.91
+94.99%
-18.07
+13.78%
-20.96
Tax Rate For Calcs
0.00
+16144.31%
0.00
-99.38%
0.00
+3.83%
0.00
Tax Effect Of Unusual Items
-3.01
-264.28%
-0.83
-130.29%
2.72
+371.16%
-1.00
Net Income Including Noncontrolling Interests
-246.91
+57.95%
-587.18
-2363.27%
25.94
+139.25%
-66.11
Net Income From Continuing Operation Net Minority Interest
-242.30
+58.90%
-589.53
-2870.33%
21.28
+132.46%
-65.55
Net Income From Continuing And Discontinued Operation
-242.30
+58.90%
-589.53
-2870.33%
21.28
+132.46%
-65.55
Net Income Continuous Operations
-246.91
+57.95%
-587.18
-2363.27%
25.94
+139.25%
-66.11
Minority Interests
4.60
+296.33%
-2.35
+49.72%
-4.66
-943.40%
0.55
Normalized Income
-233.28
-331.01%
-54.13
-512.96%
13.11
+121.01%
-62.39
Net Income Common Stockholders
-242.30
+58.90%
-589.53
-2870.33%
21.28
+132.46%
-65.55
Otherunder Preferred Stock Dividend
—
—
—
—
Diluted EPS
—
-5.72
-2851.86%
0.21
+134.18%
-0.61
Basic EPS
—
-5.72
-2851.86%
0.21
+134.18%
-0.61
Basic Average Shares
—
103.20
+2.24%
100.94
-6.07%
107.46
Diluted Average Shares
—
103.20
+1.70%
101.47
-5.58%
107.46
Diluted NI Availto Com Stockholders
-242.30
+58.90%
-589.53
-2870.33%
21.28
+132.46%
-65.55
Earnings From Equity Interest
-4.08
+72.85%
-15.02
-18.01%
-12.72
+26.13%
-17.22
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
2,649.64
-3.13%
2,735.16
-14.91%
3,214.57
+0.52%
3,197.87
Current Assets
1,484.60
-13.90%
1,724.36
+0.14%
1,721.92
-10.17%
1,916.83
Cash Cash Equivalents And Short Term Investments
871.68
-26.55%
1,186.79
-10.56%
1,326.94
-15.50%
1,570.38
Cash And Cash Equivalents
418.21
-28.84%
587.75
+37.93%
426.12
-38.64%
694.42
Other Short Term Investments
453.47
-24.30%
599.04
-33.50%
900.82
+2.84%
875.96
Receivables
209.90
-7.23%
226.25
+12.69%
200.78
+17.91%
170.29
Accounts Receivable
51.53
-47.83%
98.77
+72.62%
57.22
+58.92%
36.01
Gross Accounts Receivable
182.24
-12.47%
208.19
+185.78%
72.85
+47.97%
49.23
Allowance For Doubtful Accounts Receivable
-130.71
-19.46%
-109.41
-600.07%
-15.63
-18.19%
-13.22
Other Receivables
16.30
-32.81%
24.25
+4.74%
23.16
+56.61%
14.79
Taxes Receivable
48.57
+268.15%
13.19
+25.35%
10.52
+96.27%
5.36
Accrued Interest Receivable
12.16
-26.11%
16.46
-21.37%
20.94
+41.34%
14.81
Loans Receivable
80.57
+11.36%
72.35
-9.25%
79.73
+20.92%
65.94
Inventory
233.39
+53.79%
151.75
+27.61%
118.92
-1.29%
120.48
Raw Materials
61.22
+6.88%
57.27
-5.84%
60.82
+6.58%
57.07
Finished Goods
172.17
+82.23%
94.48
+62.61%
58.10
-28.44%
81.19
Prepaid Assets
95.58
+14.80%
83.26
+52.61%
54.56
+42.10%
38.39
Restricted Cash
64.68
-2.54%
66.37
+351.63%
14.70
-1.43%
14.91
Other Current Assets
9.35
-5.89%
9.94
+64.87%
6.03
+153.02%
2.38
Total Non Current Assets
1,165.04
+15.26%
1,010.80
-32.28%
1,492.64
+16.52%
1,281.05
Net PPE
545.20
+71.38%
318.12
+35.26%
235.19
+31.33%
179.08
Gross PPE
676.13
+64.27%
411.60
+33.85%
307.51
+32.32%
232.40
Accumulated Depreciation
-130.93
-40.06%
-93.48
-29.27%
-72.32
-35.64%
-53.32
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
99.17
+0.00%
99.17
+0.00%
99.17
-38.81%
162.06
Machinery Furniture Equipment
26.91
+13.63%
23.68
+7.31%
22.07
+4.69%
21.08
Other Properties
422.60
+97.04%
214.48
+39.75%
153.47
+826.14%
16.57
Leases
127.45
+71.60%
74.28
+126.42%
32.80
+0.36%
32.69
Goodwill And Other Intangible Assets
144.78
+13.73%
127.30
-81.44%
685.95
-3.38%
709.97
Goodwill
0.68
+0.00%
0.68
-99.87%
540.69
+0.00%
540.69
Other Intangible Assets
144.10
+13.81%
126.61
-12.83%
145.25
-14.19%
169.28
Investments And Advances
274.75
-1.97%
280.28
+7.38%
261.02
+14.50%
227.96
Non Current Deferred Assets
69.31
-18.41%
84.95
+8.86%
78.03
+20.54%
64.74
Non Current Deferred Taxes Assets
69.31
-18.41%
84.95
+8.86%
78.03
+20.54%
64.74
Non Current Prepaid Assets
63.08
-49.27%
124.33
-23.48%
162.48
+1030.67%
14.37
Other Non Current Assets
0.48
-89.20%
4.46
-62.64%
11.94
+248.60%
3.43
Total Liabilities Net Minority Interest
980.82
+26.32%
776.43
+18.86%
653.25
+10.72%
590.00
Current Liabilities
784.05
+24.41%
630.21
+16.61%
540.42
+0.44%
538.04
Payables And Accrued Expenses
344.88
+12.41%
306.81
+11.58%
274.98
-6.68%
294.65
Payables
289.15
+11.85%
258.52
+15.30%
224.21
-7.23%
241.70
Other Payable
245.07
+24.92%
196.18
+17.52%
166.93
+3.54%
161.22
Current Accrued Expenses
55.73
+15.41%
48.29
-4.88%
50.77
-4.13%
52.95
Total Tax Payable
43.46
-29.75%
61.86
+8.73%
56.89
-23.71%
74.58
Income Tax Payable
11.21
-56.92%
26.03
+4.77%
24.85
-35.51%
38.53
Current Debt And Capital Lease Obligation
116.35
+1.46%
114.68
+92.53%
59.56
+18.45%
50.28
Current Debt
39.81
-42.94%
69.77
+133.93%
29.82
—
Other Current Borrowings
39.81
-42.94%
69.77
+133.93%
29.82
—
Current Capital Lease Obligation
76.54
+70.44%
44.91
+51.00%
29.74
-40.86%
50.28
Current Deferred Liabilities
292.64
+53.73%
190.37
-2.48%
195.21
+7.45%
181.67
Current Deferred Revenue
292.64
+53.73%
190.37
-2.48%
195.21
+7.45%
181.67
Other Current Liabilities
30.18
+64.42%
18.36
+72.06%
10.67
-6.68%
11.43
Total Non Current Liabilities Net Minority Interest
196.76
+34.56%
146.22
+29.60%
112.83
+117.12%
51.97
Long Term Debt And Capital Lease Obligation
183.36
+46.46%
125.20
+45.23%
86.21
+311.07%
20.97
Long Term Capital Lease Obligation
183.36
+46.46%
125.20
+45.23%
86.21
+311.07%
20.97
Non Current Deferred Liabilities
10.62
-46.27%
19.76
-21.23%
25.08
-19.07%
30.99
Non Current Deferred Taxes Liabilities
10.62
-46.27%
19.76
-21.23%
25.08
-19.07%
30.99
Other Non Current Liabilities
2.78
+120.17%
1.26
-17.71%
1.54
—
Stockholders Equity
1,553.32
-15.54%
1,839.12
-24.75%
2,444.13
-2.15%
2,497.93
Common Stock Equity
1,553.32
-15.54%
1,839.12
-24.75%
2,444.13
-2.15%
2,497.93
Capital Stock
0.29
+1.38%
0.29
+5.45%
0.28
+0.73%
0.27
Common Stock
0.29
+1.38%
0.29
+5.45%
0.28
+0.73%
0.27
Share Issued
91.02
+1.24%
89.90
+4.91%
85.69
+0.73%
85.07
Ordinary Shares Number
77.09
-0.73%
77.66
+2.97%
75.42
-6.71%
80.84
Treasury Shares Number
13.93
+13.80%
12.24
+19.22%
10.27
+143.11%
4.22
Additional Paid In Capital
3,059.76
-0.33%
3,069.80
-0.35%
3,080.43
+1.20%
3,043.97
Retained Earnings
-1,174.59
-26.79%
-926.39
-180.58%
-330.17
+4.75%
-346.62
Gains Losses Not Affecting Retained Earnings
59.79
-17.09%
72.11
+38.57%
52.04
+57.06%
33.13
Treasury Stock
391.94
+4.05%
376.69
+5.09%
358.45
+53.95%
232.84
Minority Interest
115.50
-3.43%
119.61
+2.07%
117.19
+6.59%
109.94
Other Equity Adjustments
59.79
-17.09%
72.11
+38.57%
52.04
+57.06%
33.13
Total Equity Gross Minority Interest
1,668.82
-14.80%
1,958.73
-23.53%
2,561.31
-1.79%
2,607.87
Total Capitalization
1,553.32
-15.54%
1,839.12
-24.75%
2,444.13
-2.15%
2,497.93
Working Capital
700.54
-35.97%
1,094.15
-7.39%
1,181.50
-14.31%
1,378.79
Invested Capital
1,593.13
-16.54%
1,908.89
-22.84%
2,473.95
-0.96%
2,497.93
Total Debt
299.71
+24.95%
239.88
+64.55%
145.77
+104.57%
71.26
Capital Lease Obligations
259.90
+52.79%
170.10
+46.71%
115.95
+62.72%
71.26
Net Tangible Assets
1,408.53
-17.72%
1,711.82
-2.64%
1,758.18
-1.66%
1,787.95
Tangible Book Value
1,408.53
-17.72%
1,711.82
-2.64%
1,758.18
-1.66%
1,787.95
Duefrom Related Parties Current
0.77
-36.45%
1.22
-86.78%
9.21
-72.40%
33.38
Dueto Related Parties Current
0.62
+29.56%
0.48
+22.94%
0.39
-93.42%
5.89
Inventories Adjustments Allowances
—
—
-17.04
+4.13%
-17.78
Non Current Note Receivables
67.44
-5.49%
71.36
+22.95%
58.03
-28.79%
81.50
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-105.39
-311.15%
-25.63
-213.92%
22.50
+119.93%
-112.87
Cash Flow From Continuing Operating Activities
-105.39
-311.15%
-25.63
-213.92%
22.50
+119.93%
-112.87
Net Income From Continuing Operations
-246.91
+57.95%
-587.18
-2363.27%
25.94
+139.25%
-66.11
Depreciation Amortization Depletion
57.21
+24.60%
45.92
-0.37%
46.09
-2.12%
47.09
Depreciation
—
—
20.74
-4.19%
21.65
Amortization Cash Flow
—
—
25.35
-0.35%
25.44
Depreciation And Amortization
57.21
+24.60%
45.92
-0.37%
46.09
-2.12%
47.09
Amortization Of Intangibles
—
—
25.35
-0.35%
25.44
Other Non Cash Items
57.77
+20.91%
47.78
+4.56%
45.70
+18.43%
38.59
Stock Based Compensation
8.92
-72.69%
32.66
-10.09%
36.32
-16.19%
43.34
Provisionand Write Offof Assets
1.51
-55.54%
3.40
+563.62%
-0.73
+56.34%
-1.68
Asset Impairment Charge
41.00
-93.18%
600.95
+3452.34%
16.92
-39.45%
27.94
Deferred Tax
-1.79
+88.92%
-16.17
+51.76%
-33.52
-35.12%
-24.80
Deferred Income Tax
-1.79
+88.92%
-16.17
+51.76%
-33.52
-35.12%
-24.80
Operating Gains Losses
3.00
-79.82%
14.86
+80.67%
8.22
-53.72%
17.77
Gain Loss On Investment Securities
-0.04
+98.08%
-2.13
+36.11%
-3.33
-6904.08%
0.05
Net Foreign Currency Exchange Gain Loss
-5.95
-5210.71%
-0.11
-116.92%
0.66
+34.55%
0.49
Gain Loss On Sale Of PPE
4.07
-34.32%
6.20
+4455.15%
0.14
+2620.00%
0.01
Change In Working Capital
-26.11
+84.44%
-167.85
-37.08%
-122.44
+37.21%
-195.00
Change In Receivables
29.72
+148.35%
-61.48
-64.73%
-37.32
-311.56%
17.64
Changes In Account Receivables
21.77
+136.05%
-60.38
-108.57%
-28.95
-313.43%
13.56
Change In Inventory
-115.98
-215.58%
-36.75
-1631.90%
-2.12
+92.42%
-27.99
Change In Prepaid Assets
-45.75
-11.93%
-40.88
+18.98%
-50.45
-4.54%
-48.26
Change In Payables And Accrued Expense
175.23
+166.00%
65.88
+113.91%
30.80
+258.32%
-19.45
Change In Accrued Expense
154.56
+452.77%
27.96
+53.93%
18.16
+216.42%
-15.60
Change In Payable
20.67
-45.48%
37.92
+200.18%
12.63
+428.16%
-3.85
Change In Other Working Capital
-9.02
+66.23%
-26.70
-113.38%
-12.51
+50.14%
-25.10
Change In Other Current Assets
-3.53
+88.20%
-29.94
-626.93%
5.68
+111.07%
-51.34
Change In Other Current Liabilities
-56.79
-49.51%
-37.98
+32.79%
-56.52
-39.53%
-40.51
Investing Cash Flow
-42.81
-116.65%
257.04
+226.86%
-202.61
+64.59%
-572.21
Cash Flow From Continuing Investing Activities
-42.81
-116.65%
257.04
+226.86%
-202.61
+64.59%
-572.21
Net PPE Purchase And Sale
-196.62
-214.73%
-62.47
-22.79%
-50.88
-226.03%
-15.61
Purchase Of PPE
-196.62
-214.35%
-62.55
-22.22%
-51.18
-225.82%
-15.71
Sale Of PPE
0.00
-100.00%
0.08
-74.25%
0.30
+193.14%
0.10
Capital Expenditure
-196.62
-214.35%
-62.55
-22.22%
-51.18
-225.82%
-15.71
Net Investment Purchase And Sale
153.31
-50.34%
308.73
+283.12%
-168.59
+61.77%
-440.99
Purchase Of Investment
-872.28
+28.41%
-1,218.38
+46.37%
-2,271.69
-88.40%
-1,205.77
Sale Of Investment
1,025.60
-32.84%
1,527.11
-27.39%
2,103.09
+174.99%
764.78
Net Business Purchase And Sale
0.00
-100.00%
3.40
-48.25%
6.57
+106.74%
-97.49
Purchase Of Business
—
0.00
0.00
+100.00%
-97.49
Gain Loss On Sale Of Business
0.00
0.00
+100.00%
-5.50
0.00
Net Other Investing Changes
0.50
-93.22%
7.38
-28.32%
10.29
+156.76%
-18.13
Financing Cash Flow
-63.70
-196.13%
-21.51
+78.49%
-100.02
-636.16%
-13.59
Cash Flow From Continuing Financing Activities
-63.70
-196.13%
-21.51
+78.49%
-100.02
-636.16%
-13.59
Net Issuance Payments Of Debt
-30.00
-175.00%
40.00
+34.12%
29.82
0.00
Issuance Of Debt
100.00
-9.09%
110.00
+268.82%
29.82
0.00
Repayment Of Debt
-130.00
-85.71%
-70.00
0.00
0.00
Short Term Debt Issuance
100.00
-9.09%
110.00
+268.82%
29.82
0.00
Short Term Debt Payments
-130.00
-85.71%
-70.00
0.00
0.00
Net Short Term Debt Issuance
-30.00
-175.00%
40.00
+34.12%
29.82
0.00
Net Common Stock Issuance
-15.25
+16.36%
-18.24
+85.48%
-125.62
-730.64%
-15.12
Common Stock Payments
-15.25
+16.36%
-18.24
+85.48%
-125.62
-730.64%
-15.12
Common Stock Dividend Paid
-19.03
+56.33%
-43.57
0.00
0.00
Cash Dividends Paid
-19.03
+56.33%
-43.57
0.00
0.00
Repurchase Of Capital Stock
-15.25
+16.36%
-18.24
+85.48%
-125.62
-730.64%
-15.12
Proceeds From Stock Option Exercised
0.08
-73.49%
0.30
+55.21%
0.19
-78.08%
0.88
Net Other Financing Charges
0.50
—
-4.41
-767.78%
0.66
Changes In Cash
-211.90
-200.96%
209.89
+174.93%
-280.12
+59.91%
-698.67
Effect Of Exchange Rate Changes
-1.48
-144.38%
3.33
-71.89%
11.87
-78.76%
55.86
Beginning Cash Position
645.97
+49.27%
432.74
-38.27%
701.00
-47.83%
1,343.81
End Cash Position
432.59
-33.03%
645.97
+49.27%
432.74
-38.27%
701.00
Free Cash Flow
-302.01
-242.49%
-88.18
-207.52%
-28.68
+77.70%
-128.58
Income Tax Paid Supplemental Data
9.77
-15.79%
11.60
-28.65%
16.26
+43.11%
11.36
Change In Income Tax Payable
1.90
-85.18%
12.81
+885.89%
-1.63
-105.98%
27.24
Change In Tax Payable
1.90
-85.18%
12.81
+885.89%
-1.63
-105.98%
27.24
Common Stock Issuance
—
—
—
—
Earnings Losses From Equity Investments
4.92
-54.90%
10.90
-32.92%
16.26
-5.61%
17.22
Issuance Of Capital Stock
—
—
—
—
Sale Of Business
0.00
-100.00%
3.40
-48.25%
6.57
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category